Antonio Suppa, MD, PhD is an expert in Neurology at Istituto Neurologico Mediterraneo (Italy). As of October 2026, ScienceLeadR ranks Antonio Suppa in the top 1% of experts worldwide for Parkinson Disease, Basal Ganglia Diseases and Machine Learning. Antonio Suppa has authored 252 publications, the most recent in 2026, and is an investigator in 11 clinical trials, 9 of them ongoing. SLR score: 1,034 (community average: 125). How the SLR is computed.

LeadR Profile

Antonio Suppa, MD, PhD Istituto Neurologico Mediterraneo Italy
1 034 ScienceLeadR Reputation 1034
Network Map

Neurology

Subspecialties: Physical Medicine - Genetics - Rheumatology

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Organizations

Career arc: 2007 - 2026

Source: PubMed

Sapienza University of Rome

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 252

Citations

Citations: 7 817 1st author: 38 Last author: 62 Unique author: 3


Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Digital Motor Profiling in Parkinson's Disease: Long-Term Monitoring Through Wearable Sensors.
PMID 42939327 — dyskinesias, parkinson disease, gait, cluster analysis, therapeutics, wearables and biometrics sensors
Brain Sci20260
Fatigue and fatigability in Parkinson's disease: a neurophysiological perspective.
PMID 42735501 — parkinson disease, signs and symptoms, fatigue, neurophysiology
Clin Neurophysiol20260
Different psychological and quality-of-life outcomes after subthalamic nucleus deep brain stimulation in Parkinson's disease patients: a prospective study.
PMID 42731544 — depression, quality of life, growth, parkinson disease, brain, tremor, movement disorders, deep brain stimulation, nervous system diseases, prospective studies, subthalamic nucleus, psychological well-being
Parkinsonism Relat Disord20260
Conscious vision: investigating visual hallucination awareness in Lewy body disease.
PMID 42719585 — neuropsychology, lewy bodies, vision, ocular, neuroimaging, hallucinations, brain, perception, lewy body disease
Brain Commun20260
L-Dopa/Carbidopa intestinal gel infusion in advanced Parkinson's disease: real-life mobility insights from wearable sensors.
PMID 42376452 — dyskinesias, parkinson disease, gait, carbidopa, therapeutics, levodopa, wearables and biometrics sensors
Front Neurol20261

Clinical Studies 11

Sources: ClinicalTrials, EU CTIS

Synthesis

By phase:

N/A 8
Phase 3 3

By status:

Recruiting 7
Active not recruiting 2
Completed 1
Not yet recruiting 1

By type:

Observational 7
Interventional 4

By Monocentric/Multicentric:

monocentric 7
multicentric2to4 2
multicentric5to9 0
multicentricup10 2

Main Topics

Cohort/Consortium Investigators 1

Ongoing Clinical Trials

9 ongoing trials started since 2021, where this expert is an investigator

Source: ClinicalTrials

Study Phase Status Start
A Study to Assess Efficacy and Safety of Empasiprubart Versus IVIg in Adults With CIDP
NCT06920004 — safety, immunoglobulins, polyneuropathies, polyradiculoneuropathy, chronic inflammatory demyelinating, polyradiculoneuropathy, therapeutics, infusions, intravenous, immunoglobulins, intravenous
Phase 3Recruiting2025
Integrated Management of Atypical Parkinsonism A Home based Patient Centered Healthcare Delivery Based on Telenursing (IMPACT Study)
NCT05792332 — nurses, telenursing, atrophy, multiple system atrophy, parkinsonian disorders, nurse-patient relations, physicians, shy-drager syndrome, physician-nurse relations, nurse specialists, neurologists
N/AActive not recruiting2023
Observational Longitudinal Study on the Outbreak and Management of Stroke Related Spasticity
NCT05379413 — injections, muscle spasticity, longitudinal studies, muscles, stroke, rehabilitation, botulinum toxins, type a, botulinum toxins, therapeutics, neurotoxins
N/ANot yet recruiting2022
Instrumental Assessment of Motor Symptoms by Means of Wearable Sensors in Patients With Parkinson s Disease
NCT05349539 — parkinson disease, motor disorders, gait, signs and symptoms, wearables and biometrics sensors
N/ARecruiting2022
Handwriting Analysis in Movement Disorders
NCT05355480 — parkinson disease, writing, machine learning, handwriting, movement disorders, learning, movement
N/ARecruiting2022

LeadR Networks

Main global connection map